Nabumetone | compare suppliers & send inquiries for free
Divis Labs.
Chemi S.p.A.
Looking for Nabumetone 42924-53-8?
- API | Excipient name:
- Nabumetone
- Synonyms:
- Nabumeton, Nabumetona, Nabumétone, Nabumetone, Nabumetonum, Relafen
- Cas Number:
- 42924-53-8
- DrugBank number:
- DB00461
- Unique Ingredient Identifier:
- LW0TIW155Z
About Nabumetone
More information about this product: Nabumetone was originally developed as a non-acidic non-steroidal anti-inflammatory drug (NSAID). It was thought to avoid trapping of the drug in the stomach by making it unable to dissociate into ions which was believed to reduce GI toxicity by limiting local action. While slightly reduced, possibly due to a degree of cyclooxygenase-2 selectivity (COX-2), nabumetone still produces significant adverse effects in the GI tract.1 The molecule itself is a pro-drug with its 6-methoxy-2-naphthylacetic acid (6-MNA) metabolite acting as a potent COX inhibitor similar in structure to naproxen.
Nabumetone was developed by Smithkline Beecham under the trade name Relafen and first received FDA approval in December, 1991.
You can find more info about this product by clicking on the DB ID above.
Nabumetone manufacturers | traders | suppliers
We have 5 companies offering Nabumetone from 2 different countries.
Get in contact with the supplier of your choice:
- Lupin from India
- Divis Labs. from India
- Chemi S.p.A. from Italy
- Watson Pharma from India
- Strides Pharma Science from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.